LRRK2 in Parkinson's disease - Drawing the curtain of penetrance: A commentary

BMC Medicine

Volumn 6, Issue , 2008, Pages

  Krüger, Rejko ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT INHERITANCE; ENVIRONMENTAL FACTOR; ETHNICITY; FAMILIAL DISEASE; FAMILY STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MUTATIONAL ANALYSIS; NEUROPROTECTION; NOTE; PARKINSON DISEASE; PEDIGREE; PENETRANCE; PHENOTYPE; POPULATION GENETICS; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PENETRANCE; PROTEIN-SERINE-THREONINE KINASES;

EID: 58149120916     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-6-33     Document Type: Note

References (24)

1. Schiesling C Kieper N Seidel K Krüger R Familial PD - genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease Neuropathol Appl Neurobiol 2008, 34:255-271 10.1111/ j.1365-2990.2008.00952.x 18447897
2. Zimprich A Biskup S Leitner P Lichtner P Farrer M Lincoln S Kachergus J Hulihan M Uitti RJ Calne DB Stoessl AJ Pfeiffer RF Patenge N Carbajal IC Vieregge P Asmus F Muller-Myhsok B Dickson DW Meitinger T Strom TM Wszolek ZK Gasser T Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 2004, 44:601-607 10.1016/ j.neuron.2004.11.005 15541309
3. Paisan-Ruiz C Jain S Evans EW Gilks WP Simon J Brug van der M Lopez de Munain A Aparicio S Gil AM Khan N Johnson J Martinez JR Nicholl D Carrera IM Pena AS de Silva R Lees A Marti-Masso JF Perez-Tur J Wood NW Singleton AB Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 2004, 44:595-600 10.1016/ j.neuron.2004.10.023 15541308
4. Berg D Schweitzer K Leitner P Zimprich A Lichtner P Belcredi P Brussel T Schulte C Maass S Nagele T Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease Brain 2005, 128:3000-3011 16251215
5. Lesage S Durr A Tazir M Lohmann E Leutenegger AL Janin S Pollak P Brice A LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs N Engl J Med 2006, 354:422-423 10.1056/NEJMc055540 16436781
6. Healy DG Falchi M O'Sullivan SS Bonifati V Durr A Bressman S Brice A Aasly J Zabetian CP Goldwurm S Ferreira JJ Tolosa E Kay DM Klein C Williams DR Marras C Lang AE Wszolek ZK Berciano J Schapira AH Lynch T Bhatia KP Gasser T Lees AJ Wood NW International LRRK2 Consortium Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study Lancet Neurol 2008, 7:583-590 10.1016/S1474-4422(08)70117-0 18539534
7. Hulihan MM Ishihara-Paul L Kachergus J Warren L Amouri R Elango R Prinjha RK Upmanyu R Kefi M Zouari M Sassi SB Yahmed SB El Euch Fayeche G Matthews PM Middleton LT Gibson RA Hentati F Farrer MJ LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: A case-control genetic study Lancet Neurol 2008, 7:591-594 10.1016/ S1474-4422(08)70116-9 18539535
8. Di Fonzo A Rohe CF Ferreira J Chien HF Vacca L Stocchi F Guedes L Fabrizio E Manfredi M Vanacore N Goldwurm S Breedveld G Sampaio C Meco G Barbosa E Oostra BA Bonifati V A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease Lancet 2005, 365:412-415 15680456
9. Mata IF Wedemeyer WJ Farrer MJ Taylor JP Gallo KA LRRK2 in Parkinson's disease: Protein domains and functional insights Trends Neurosci 2006, 29:286-293 10.1016/j.tins.2006.03.006 16616379
10. Goldwurm S Zini M Mariani L Tesei S Miceli R Sironi F Clementi M Bonifati V Pezzoli G Evaluation of LRRK2 G2019S penetrance Neurology 2007, 68:1141-1143 10.1212/01.wnl.0000254483.19854.ef 17215492
11. Latourelle JC Sun M Lew MF Suchowersky O Klein C Golbe LI Mark MH Growdon JH Wooten F et al. The G2019S mutation in LRRK2 is not fully penetrant: The GenePD study BMC Medicine 2008 18986508 2596771
12. Ozelius LJ Senthil G Saunders-Pullman R Ohmann E Deligtisch A Tagliati M Hunt AL Klein C Henick B Hailpern SM Lipton RB Soto-Valencia J Risch N Bressman SB LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews N Engl J Med 2006, 354:424-425 10.1056/NEJMc055509 16436782
13. Begg CB On the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 2002, 94:221-226 12189225
14. Polymeropoulos MH Lavedan C Leroy E Ide SE Dehejia A Dutra A Pike B Root H Rubenstein J Boyer R Stenroos ES Chandrasekharappa S Athanassiadou A Papapetropoulos T Johnson WG Lazzarini AM Duvoisin RC Di Iorio G Golbe LI Nussbaum RL Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 1997, 276:2045-2047 10.1126/ science.276.5321.2045 9197268
15. Pramstaller PP Schlossmacher MG Jacques TS Scaravilli F Eskelson C Pepivani I Hedrich K Adel S Gonzales-McNeal M Hilker R Kramer PL Klein C Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers Ann Neurol 2005, 58:411-422 10.1002/ana.20587 16130111
16. Schrag A Ben-Shlomo Y Quinn NP Cross-sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London BMJ 2000, 321:21-22 27420 10875828 10.1136/bmj.321.7252.21
17. Hedrich K Hagenah J Djarmati A Hiller A Lohnau T Lasek K Grunewald A Hilker R Steinlechner S Boston H Kock N Schneider-Gold C Kress W Siebner H Binkofski F Lencer R Munchau A Klein C Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: Role of a single hit? Arch Neurol 2006, 63:833-838 10.1001/ archneur.63.6.833 16769864
18. Klein C Lohmann-Hedrich K Rogaeva E Schlossmacher MG Lang AE Deciphering the role of heterozygous mutations in genes associated with parkinsonism Lancet Neurol 2007, 6:652-662 10.1016/S1474-4422(07)70174-6 17582365
19. Haugarvoll K Rademakers R Kachergus JM Nuytemans K Ross OA Gibson JM Tan EK Gaig C Tolosa E Goldwurm S Guidi M Riboldazzi G Brown L Walter U Benecke R Berg D Gasser T Theuns J Pals P Cras P Paul De Deyn P Engelborghs S Pickut B Uitti RJ Foroud T Nichols WC Hagenah J Klein C Samii A Zabetian CP Bonifati V Van Broeckhoven C Farrer MJ Wszolek ZK Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease Neurology 2008, 70:1456-1460 10.1212/01.wnl.0000304044.22253.03 18337586
20. Maraganore DM de Andrade M Elbaz A Farrer MJ Ioannidis JP Kruger R Rocca WA Schneider NK Lesnick TG Lincoln SJ Hulihan MM Aasly JO Ashizawa T Chartier-Harlin MC Checkoway H Ferrarese C Hadjigeorgiou G Hattori N Kawakami H Lambert JC Lynch T Mellick GD Papapetropoulos S Parsian A Quattrone A Riess O Tan EK Van Broeckhoven C Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease JAMA 2006, 296:661-670 10.1001/jama.296.6.661 16896109
21. Fuchs J Tichopad A Golub Y Munz M Schweitzer KJ Wolf B Berg D Mueller JC Gasser T Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain FASEB J 2008, 22:1327-1334 10.1096/ fj.07-9348com 18162487
22. Dächsel JC Mata IF Ross OA Taylor JP Lincoln SJ Hinkle KM Huerta Ribacoba R Blazquez M Alvarez V Farrer MJ Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2 Neurosci Lett 2006, 410:80-84 10.1016/j.neulet.2006.06.068 17095157
23. Marras C Klein C Lang AE Wakutani Y Moreno D Sato C Yip E Munhoz RP Lohmann K Djarmati A Bi A Rogaeva E LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation Neurobiol Aging 2008 18644660
24. Hardy J No definitive evidence for a role for the environment in the etiology of Parkinson's disease Mov Disord 2006, 21:1790-1791 10.1002/ mds.21067 16941458